9. International Drug Chemistry Conference, Antalya, Türkiye, 08 Nisan 2021, ss.117
Aldose reductase is an enzyme that is
responsible for the convertion of glucose to sorbitol. Increased activity of
this pathway has been associated with diabetic complications thus making aldose
reductase enzyme a pharmacological target(1).There are some compounds
which were evaulated in clinical trials bearing pyridazinone moiety like ponalrestat.
So, pyridazinone is a heterocyclic core having
a potential for inhibiton of aldose reductase and chalcones are priviliged structures
having antioxidant activity(2,,3).Moreover, after tetramethyleneglutaric
acid had been shown as a aldose reductase inhibitor, various acid derivatives
were synthesized and evaluated for aldose reductase inhibition(4). Given
these data,combination of these structures can give rise to potent inhibitors
of aldose reductase and also antioxidant compounds. In this study, we synthesized
a representing compound of 2-(6-Chalconoxy-Pyridazin-3(2H)-One) Acetic Acid serie
and performed molecular modelling studies of this compound. The success of
sythesis was comfirmed evaluating 1H-NMR and LC-MS spectra.